Thyroid : official journal of the American Thyroid Association
Journal
Overview
publication venue for
-
RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance..
34.
2024
-
Regulation of thyroid hormone levels by hypothalamic TRH (thyrotropin-releasing hormone) neurons.
2023
-
A Comparison of Outcomes in Medullary Thyroid Carcinoma Patients With and Without a Preoperative Diagnosis: A Multicenter Retrospective Cohort Study..
33.
2023
-
Prepubertal Children with Papillary Thyroid Carcinoma Present with More Invasive Disease than Adolescents and Young Adults.
2022
-
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns..
32.
2022
-
Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.
2022
-
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial..
32.
2022
-
The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study..
31.
2021
-
CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer..
31.
2021
-
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples..
31.
2020
-
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies..
30.
2020
-
Nondiagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants..
30.
2020
-
Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma..
30.
2020
-
Insurance Status Is Associated with Extent of Treatment for Patients with Papillary Thyroid Carcinoma..
29.
2019
-
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance..
29.
2019
-
Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment..
29.
2019
-
Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha..
29.
2019
-
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness..
29.
2018
-
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease..
28.
2018
-
Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer..
28.
2018
-
Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer..
28.
2018
-
Concurrent Milk Ingestion Decreases Absorption of Levothyroxine..
28.
2018
-
Information for Clinicians: Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer-When to Use Systemic Therapy..
27.
2017
-
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations..
27.
2017
-
Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features..
27.
2017
-
Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer..
27.
2017
-
Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics..
27.
2017
-
Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer..
27.
2017
-
Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas..
26.
2016
-
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers..
26.
2016
-
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer..
26.
2016
-
Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer..
26.
2016
-
Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes..
26.
2016
-
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma..
26.
2015
-
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?.
25.
2015
-
Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence..
25.
2015
-
Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure..
25.
2015
-
Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer..
25.
2015
-
Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer..
25.
2015
-
Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma..
25.
2015
-
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma..
25.
2014
-
Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer..
24.
2014
-
Response to initial therapy predicts clinical outcomes in medullary thyroid cancer..
25.
2014
-
Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer..
24.
2014
-
Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases..
24.
2014
-
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)..
24.
2014
-
Prognostic implications of papillary thyroid carcinoma with tall-cell features..
24.
2014
-
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases..
24.
2013
-
Ernest L. Mazzaferri, MD, MACP (1936-2013)..
23.
2013
-
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems..
23.
2013
-
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification..
23.
2013
-
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma..
23.
2013
-
The increasing incidence of thyroid cancer: the influence of access to care..
23.
2013
-
A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients..
23.
2013
-
Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans..
22.
2012
-
The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland..
22.
2012
-
Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer..
22.
2012
-
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension..
22.
2012
-
American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma..
22.
2012
-
Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study..
22.
2011
-
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response..
21.
2011
-
Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study..
21.
2011
-
Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma..
21.
2011
-
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006..
21.
2010
-
An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits..
21.
2010
-
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system..
20.
2010
-
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension..
20.
2010
-
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function..
20.
2010
-
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival..
20.
2010
-
Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation..
19.
2009
-
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?.
19.
2009
-
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)..
19.
2009
-
ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout..
18.
2008
-
Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications..
17.
2007
-
Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors..
17.
2007
-
Outdated and incomplete: a review of thyroid cancer on the World Wide Web..
17.
2007
-
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine..
16.
2006
-
Recombinant human thyrotropin stimulates thyroid angiogenesis in vivo..
16.
2006
-
Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors..
16.
2006
-
Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling..
15.
2005
-
Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines..
15.
2005
-
Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients..
15.
2005
-
Cytoplasmic localization of the paired box gene, Pax-8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence..
14.
2004
-
Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer..
13.
2003
-
Leucine at codon 428 in the ninth heptad of thyroid hormone receptor beta1 is necessary for interactions with the transcriptional cofactors and functions regardless of dimer formations..
13.
2003
-
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice..
12.
2002
-
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine..
11.
2001
-
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin..
11.
2001
-
The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults..
10.
2000
-
Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients..
10.
2000
-
Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I..
9.
1999
-
ret rearrangements in Japanese pediatric and adult papillary thyroid cancers..
8.
1998
-
Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease..
5.
1995
-
Reversal in Thyroid Cancer Incidence Trends in the United States, 2000-2017..
30.
2020
-
Challenges of Active Surveillance Protocols for Low-Risk Papillary Thyroid Microcarcinoma in the United States..
26.
2016
-
Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma"..
25.
2015
-
Response to Hennessey re: "Concurrent Milk Ingestion Decreases Absorption of Levothyroxine".
2018
-
Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
2015
-
The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
2014
-
Thyroglobulin-positive, radioiodine-negative thyroid cancer.
2001
-
86th Annual Meeting of the American Thyroid Association..
26.
2016
-
Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer-Primum Non Nocere and NIFTP..
26.
2016
-
Welcome to the 84th annual meeting of the American Thyroid Association..
24.
2014
-
Observing micopapillary thyroid cancers..
24.
2014
-
Ultrasonographic characterization of cervical lymphadenopathy in chronic autoimmune thyroiditis..
23.
2013
-
Thyroidectomy decreases snoring and sleep apnea: fact or fantasy?.
22.
2012
-
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer..
21.
2011
-
Expanding indications for recombinant human TSH in thyroid cancer..
18.
2008
-
Database and registry research in thyroid cancer: striving for a new and improved national thyroid cancer database.
2015
-
Improving the quality of thyroid cancer care: how does the Thyroid Cancer Care Collaborative cross the Institute of Medicine's Quality Chasm?
2014
-
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
2012
-
American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer.
2012
-
The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor.
2008
-
Autoimmune thyroid disease associated with environmental thyroidal irradiation.
2003
-
Adverse Histological Features of Differentiated Thyroid Cancer Are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines.
2021
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)